Evidence map›Paper›PMID 24906987›Full record

ArticleHeart and vessels2015

Black hole restenosis after drug-eluting stent implantation for in-stent restenosis: potential mechanism and optimal strategy.

Yoritaka Otsuka, Takashi Murata, Michiaki Kono, Hiroki Imoto, Taku Koyama, Keita Nakamura, Sunao Kadama, Hiroo Noguchi, Taro Saito

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yoritaka OtsukaDepartment of Cardiology, Fukuoka Wajiro Hospital, 2-2-75, Wajirogaoka, Higashi-ku, Fukuoka, 811-0213, Japan. yotsuka@f-wajirohp.jp.
Takashi MurataDepartment of Cardiology, Fukuoka Wajiro Hospital, 2-2-75, Wajirogaoka, Higashi-ku, Fukuoka, 811-0213, Japan.
Michiaki KonoDepartment of Cardiology, Fukuoka Wajiro Hospital, 2-2-75, Wajirogaoka, Higashi-ku, Fukuoka, 811-0213, Japan.
Hiroki ImotoDepartment of Cardiology, Fukuoka Wajiro Hospital, 2-2-75, Wajirogaoka, Higashi-ku, Fukuoka, 811-0213, Japan.
Taku KoyamaDepartment of Cardiology, Fukuoka Wajiro Hospital, 2-2-75, Wajirogaoka, Higashi-ku, Fukuoka, 811-0213, Japan.
Keita NakamuraDepartment of Cardiology, Fukuoka Wajiro Hospital, 2-2-75, Wajirogaoka, Higashi-ku, Fukuoka, 811-0213, Japan.
Sunao KadamaDepartment of Cardiology, Fukuoka Wajiro Hospital, 2-2-75, Wajirogaoka, Higashi-ku, Fukuoka, 811-0213, Japan.
Hiroo NoguchiDepartment of Cardiology, Fukuoka Wajiro Hospital, 2-2-75, Wajirogaoka, Higashi-ku, Fukuoka, 811-0213, Japan.
Taro SaitoDepartment of Cardiology, Fukuoka Wajiro Hospital, 2-2-75, Wajirogaoka, Higashi-ku, Fukuoka, 811-0213, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In-stent restenosis (ISR) has long remained as the major limitation of coronary stenting. The use of drug-eluting stent (DES) reduces the risk of repeat revascularization without an increase of death and myocardial infarction, compared to the standard bare metal stents. DES has also demonstrated markedly to reduce ISR for complex lesions. However, ISR after DES implantation still occurs and optimal treatment for ISR after DES has not been established. Herein, we report 3 cases with black hole restenosis confirmed by intravascular ultrasound at the site of overlapped DES and discuss potential mechanism and optimal strategy for this phenomenon.

Indexed as

AgedAged, 80 and overAngioplasty, Balloon, CoronaryCoronary AngiographyDrug-Eluting StentsFemaleFollow-Up StudiesGraft Occlusion, VascularHumansMaleMyocardial InfarctionReoperationSirolimusUltrasonography, InterventionalSirolimusDrug-eluting stentPercutaneous coronary interventionRestenosis

Identifiers

PMID24906987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.